TALPHERA, INC. Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic
TALPHERA, INC. (TLPH) reported Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic of -$8.11 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Income Statement › Other Income
us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic · last filed 2024-03-06
- TALPHERA, INC. net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2023-12-31 was -$12.00K.
- TALPHERA, INC. net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2023-09-30 was $61.00K.
- TALPHERA, INC. net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2023-06-30 was $57.00K.
- TALPHERA, INC. net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2023-03-31 was -$8.22M.
- TALPHERA, INC. net income (loss) from discontinued operations available to common shareholders, basic for fiscal 2023 was -$8.11M.
- TALPHERA, INC. net income (loss) from discontinued operations available to common shareholders, basic for fiscal 2022 was -$11.37M.
| Period end | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 3 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 6 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 9 month | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $49.00K derived: sum of 2 quarters · filed 2024-03-06 | $106.00K derived: sum of 3 quarters · filed 2024-03-06 | -$8.11M 10-K · filed 2024-03-06 |
| 2023-09-30 | $61.00K 10-Q · filed 2023-11-14 | $118.00K derived: sum of 2 quarters · filed 2023-11-14 | -$8.10M 10-Q · filed 2023-11-14 | -$9.65M derived: sum of 4 quarters · filed 2024-03-06 |
| 2023-06-30 | $57.00K 10-Q · filed 2023-08-10 | -$8.16M 10-Q · filed 2023-08-10 | -$9.71M derived: sum of 3 quarters · filed 2024-03-06 | -$11.82M derived: sum of 4 quarters · filed 2024-03-06 |
| 2023-03-31 | -$8.22M derived: 10-K 12 month − 3 quarters · filed 2024-03-06 | -$9.76M derived: sum of 2 quarters · filed 2024-03-06 | -$11.88M derived: sum of 3 quarters · filed 2024-03-06 | -$15.53M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-12-31 | -$1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$3.66M derived: sum of 2 quarters · filed 2024-03-06 | -$7.31M derived: sum of 3 quarters · filed 2024-03-06 | -$11.37M 10-K · filed 2024-03-06 |
| 2022-09-30 | -$2.11M 10-Q · filed 2023-11-14 | -$5.76M derived: sum of 2 quarters · filed 2023-11-14 | -$9.82M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$3.65M 10-Q · filed 2023-08-10 | -$7.71M 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |